Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.755 USD | -1.18% | -16.18% | -41.69% |
Financials (USD)
Sales 2024 * | 30.47M | Sales 2025 * | 71.52M | Capitalization | 1.01B |
---|---|---|---|---|---|
Net income 2024 * | -174M | Net income 2025 * | -127M | EV / Sales 2024 * | 10.9 x |
Net cash position 2024 * | 678M | Net cash position 2025 * | 585M | EV / Sales 2025 * | 5.95 x |
P/E ratio 2024 * |
-4.81
x | P/E ratio 2025 * |
-7.25
x | Employees | 467 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 3.32% |
Latest transcript on Autolus Therapeutics plc
1 day | -5.00% | ||
1 week | -16.67% | ||
Current month | -40.44% | ||
1 month | -40.44% | ||
3 months | -38.11% | ||
6 months | +43.94% | ||
Current year | -40.99% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Pulé
FOU | Founder | 51 | 14-08-31 |
Chief Executive Officer | 59 | 14-09-30 | |
Robert Dolski
DFI | Director of Finance/CFO | 54 | 23-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Berriman
BRD | Director/Board Member | 76 | 14-07-31 |
William Young
BRD | Director/Board Member | 79 | 21-11-14 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 3.755 | -1.18% | 2 960 380 |
24-04-29 | 3.8 | -5.00% | 5,154,280 |
24-04-26 | 4 | -1.96% | 2,745,490 |
24-04-25 | 4.08 | -3.09% | 3,872,988 |
24-04-24 | 4.21 | -6.03% | 2,720,848 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.99% | 1.01B | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.80% | 22.18B | |
-16.67% | 21.2B | |
-8.96% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- AUTL Stock